These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

299 related items for PubMed ID: 15217560

  • 1. Gene therapy for hemoglobinopathies: are we there yet?
    Puthenveetil G, Malik P.
    Curr Hematol Rep; 2004 Jul; 3(4):298-305. PubMed ID: 15217560
    [Abstract] [Full Text] [Related]

  • 2. Gene therapy for the hemoglobin disorders.
    Persons DA, Nienhuis AW.
    Curr Hematol Rep; 2003 Jul; 2(4):348-55. PubMed ID: 12901333
    [Abstract] [Full Text] [Related]

  • 3. Recent advances in globin gene transfer for the treatment of beta-thalassemia and sickle cell anemia.
    Sadelain M.
    Curr Opin Hematol; 2006 May; 13(3):142-8. PubMed ID: 16567956
    [Abstract] [Full Text] [Related]

  • 4. Globin gene transfer for treatment of the beta-thalassemias and sickle cell disease.
    Sadelain M, Rivella S, Lisowski L, Samakoglu S, Rivière I.
    Best Pract Res Clin Haematol; 2004 Sep; 17(3):517-34. PubMed ID: 15498721
    [Abstract] [Full Text] [Related]

  • 5. On the road to gene therapy for beta-thalassemia and sickle cell anemia.
    Bank A.
    Pediatr Hematol Oncol; 2008 Sep; 25(1):1-4. PubMed ID: 18231949
    [Abstract] [Full Text] [Related]

  • 6. Towards gene therapy of hemoglobinopathies.
    Beuzard Y.
    Semin Hematol; 1996 Jan; 33(1):43-52. PubMed ID: 8714584
    [No Abstract] [Full Text] [Related]

  • 7. Partial correction of murine beta-thalassemia with a gammaretrovirus vector for human gamma-globin.
    Nishino T, Tubb J, Emery DW.
    Blood Cells Mol Dis; 2006 Jan; 37(1):1-7. PubMed ID: 16814578
    [Abstract] [Full Text] [Related]

  • 8. Successful correction of the human Cooley's anemia beta-thalassemia major phenotype using a lentiviral vector flanked by the chicken hypersensitive site 4 chromatin insulator.
    Malik P, Arumugam PI, Yee JK, Puthenveetil G.
    Ann N Y Acad Sci; 2005 Jan; 1054():238-49. PubMed ID: 16339671
    [Abstract] [Full Text] [Related]

  • 9. Progress toward the genetic treatment of the beta-thalassemias.
    Sadelain M, Lisowski L, Samakoglu S, Rivella S, May C, Riviere I.
    Ann N Y Acad Sci; 2005 Jan; 1054():78-91. PubMed ID: 16339654
    [Abstract] [Full Text] [Related]

  • 10. Therapy for beta-globinopathies: a brief review and determinants for successful and safe correction.
    Perumbeti A, Malik P.
    Ann N Y Acad Sci; 2010 Aug; 1202():36-44. PubMed ID: 20712770
    [Abstract] [Full Text] [Related]

  • 11. Progress toward safe and effective gene therapy for beta-thalassemia and sickle cell disease.
    Lebensburger J, Persons DA.
    Curr Opin Drug Discov Devel; 2008 Mar; 11(2):225-32. PubMed ID: 18283610
    [Abstract] [Full Text] [Related]

  • 12. Correction of sickle cell disease in transgenic mouse models by gene therapy.
    Pawliuk R, Westerman KA, Fabry ME, Payen E, Tighe R, Bouhassira EE, Acharya SA, Ellis J, London IM, Eaves CJ, Humphries RK, Beuzard Y, Nagel RL, Leboulch P.
    Science; 2001 Dec 14; 294(5550):2368-71. PubMed ID: 11743206
    [Abstract] [Full Text] [Related]

  • 13. Current status of globin gene therapy for the treatment of beta-thalassaemia.
    Lisowski L, Sadelain M.
    Br J Haematol; 2008 May 14; 141(3):335-45. PubMed ID: 18410569
    [Abstract] [Full Text] [Related]

  • 14. Hemoglobin gene therapy for β-thalassemia.
    Bank A.
    Hematol Oncol Clin North Am; 2010 Dec 14; 24(6):1187-201. PubMed ID: 21075288
    [Abstract] [Full Text] [Related]

  • 15. Future prospects for treatment of hemoglobinopathies.
    Stamatoyannopoulos JA.
    West J Med; 1992 Dec 14; 157(6):631-6. PubMed ID: 1282285
    [Abstract] [Full Text] [Related]

  • 16. Hematopoietic stem cell mobilization strategies for gene therapy of beta thalassemia and sickle cell disease.
    Yannaki E, Stamatoyannopoulos G.
    Ann N Y Acad Sci; 2010 Aug 14; 1202():59-63. PubMed ID: 20712773
    [Abstract] [Full Text] [Related]

  • 17. A New Era for Hemoglobinopathies: More Than One Curative Option.
    Psatha N, Papayanni PG, Yannaki E.
    Curr Gene Ther; 2017 Aug 14; 17(5):364-378. PubMed ID: 29357790
    [Abstract] [Full Text] [Related]

  • 18. A phase I/II clinical trial of beta-globin gene therapy for beta-thalassemia.
    Bank A, Dorazio R, Leboulch P.
    Ann N Y Acad Sci; 2005 Aug 14; 1054():308-16. PubMed ID: 16339679
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Gene Therapy Approaches to Hemoglobinopathies.
    Ferrari G, Cavazzana M, Mavilio F.
    Hematol Oncol Clin North Am; 2017 Oct 14; 31(5):835-852. PubMed ID: 28895851
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.